Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1,500 35 40 35 40 B-lower_bound
cells 41 46 41 46 I-lower_bound
/ 46 47 46 47 I-lower_bound
mm^3 47 51 47 51 I-lower_bound

Aspartate 0 9 52 61 B-clinical_variable
aminotransferase 10 26 62 78 I-clinical_variable
( 27 28 79 80 I-clinical_variable
AST 28 31 80 83 I-clinical_variable
) 31 32 83 84 I-clinical_variable
and 33 36 85 88 O
alanine 37 44 89 96 B-clinical_variable
aminotransferase 45 61 97 113 I-clinical_variable
( 62 63 114 115 I-clinical_variable
ALT 63 66 115 118 I-clinical_variable
) 66 67 118 119 I-clinical_variable
< 68 69 120 121 O
6 70 71 122 123 B-upper_bound
times 72 77 124 129 I-upper_bound
upper 78 83 130 135 I-upper_bound
limit 84 89 136 141 I-upper_bound
of 90 92 142 144 I-upper_bound
normal 93 99 145 151 I-upper_bound
( 100 101 152 153 I-upper_bound
ULN 101 104 153 156 I-upper_bound
) 104 105 156 157 I-upper_bound

At 0 2 158 160 O
least 3 8 161 166 O
one 9 12 167 170 B-lower_bound
solid 13 18 171 176 B-cancer
liver 19 24 177 182 I-cancer
lesion 25 31 183 189 I-cancer
or 32 34 190 192 O
vascular 35 43 193 201 B-cancer
tumor 44 49 202 207 I-cancer
thrombosis 50 60 208 218 I-cancer
( 61 62 219 220 O
involving 62 71 220 229 O
portal 72 78 230 236 O
vein 79 83 237 241 O
, 83 84 241 242 O
inferior 85 93 243 251 O
vena 94 98 252 256 O
cava 99 103 257 261 O
[ 104 105 262 263 O
IVC 105 108 263 266 O
] 108 109 266 267 O
and/or 110 116 268 274 O
hepatic 117 124 275 282 O
vein 125 129 283 287 O
) 129 130 287 288 O
> 131 132 289 290 O
1 133 134 291 292 B-lower_bound
cm 135 137 293 295 I-lower_bound
with 138 142 296 300 O
arterial 143 151 301 309 O
enhancement 152 163 310 321 O
and 164 167 322 325 O
delayed 168 175 326 333 O
washout 176 183 334 341 O
on 184 186 342 344 O
multi 187 192 345 350 B-treatment
- 192 193 350 351 I-treatment
phasic 193 199 351 357 I-treatment
computerized 200 212 358 370 I-treatment
tomography 213 223 371 381 I-treatment
( 224 225 382 383 I-treatment
CT 225 227 383 385 I-treatment
) 227 228 385 386 I-treatment
or 229 231 387 389 O
magnetic 232 240 390 398 B-treatment
resonance 241 250 399 408 I-treatment
imaging 251 258 409 416 I-treatment
( 259 260 417 418 I-treatment
MRI 260 263 418 421 I-treatment
) 263 264 421 422 I-treatment
in 265 267 423 425 O
the 268 271 426 429 O
setting 272 279 430 437 O
of 280 282 438 440 O
cirrhosis 283 292 441 450 B-chronic_disease
or 293 295 451 453 O
chronic 296 303 454 461 B-chronic_disease
hepatitis 304 313 462 471 I-chronic_disease
B 314 315 472 473 I-chronic_disease
or 316 318 474 476 I-chronic_disease
C 319 320 477 478 I-chronic_disease
without 321 328 479 486 O
cirrhosis 329 338 487 496 O

Barcelona 0 9 497 506 O
Clinic 10 16 507 513 O
Liver 17 22 514 519 O
Cancer 23 29 520 526 O
( 30 31 527 528 O
BCLC 31 35 528 532 O
) 35 36 532 533 O
stage 37 42 534 539 O
: 42 43 539 540 O
intermediate 44 56 541 553 O
( 57 58 554 555 O
B 58 59 555 556 O
) 59 60 556 557 O
or 61 63 558 560 O
advanced 64 72 561 569 O
( 73 74 570 571 O
C 74 75 571 572 O
) 75 76 572 573 O
within 77 83 574 580 O
28 84 86 581 583 B-upper_bound
days 87 91 584 588 I-upper_bound
prior 92 97 589 594 I-upper_bound
to 98 100 595 597 O
study 101 106 598 603 O
entry 107 112 604 609 O

Child 0 5 610 615 B-clinical_variable
- 5 6 615 616 I-clinical_variable
Pugh 6 10 616 620 I-clinical_variable
score 11 16 621 626 I-clinical_variable
A 17 18 627 628 O
within 19 25 629 635 O
14 26 28 636 638 B-upper_bound
days 29 33 639 643 I-upper_bound
prior 34 39 644 649 I-upper_bound
to 40 42 650 652 O
study 43 48 653 658 O
entry 49 54 659 664 O

Direct 0 6 665 671 O
tumor 7 12 672 677 B-cancer
extension 13 22 678 687 O
into 23 27 688 692 O
the 28 31 693 696 O
stomach 32 39 697 704 B-cancer
, 39 40 704 705 O
duodenum 41 49 706 714 B-cancer
, 49 50 714 715 O
small 51 56 716 721 B-cancer
bowel 57 62 722 727 I-cancer
or 63 65 728 730 O
large 66 71 731 736 B-cancer
bowel 72 77 737 742 I-cancer

Extrahepatic 0 12 743 755 B-cancer
metastases 13 23 756 766 I-cancer
or 24 26 767 769 O
malignant 27 36 770 779 B-cancer
nodes 37 42 780 785 I-cancer
( 43 44 786 787 O
that 44 48 787 791 O
enhance 49 56 792 799 O
with 57 61 800 804 O
typical 62 69 805 812 O
features 70 78 813 821 O
of 79 81 822 824 O
HCC 82 85 825 828 B-clinical_variable
) 85 86 828 829 O
> 87 88 830 831 O
3.0 89 92 832 835 B-lower_bound
cm 93 95 836 838 I-lower_bound
, 95 96 838 839 O
in 97 99 840 842 O
sum 100 103 843 846 O
of 104 106 847 849 O
maximal 107 114 850 857 O
diameters 115 124 858 867 O
( 125 126 868 869 O
e.g. 126 130 869 873 O
presence 131 139 874 882 O
of 140 142 883 885 O
one 143 146 886 889 O
3.4 147 150 890 893 O
cm 151 153 894 896 O
metastatic 154 164 897 907 B-cancer
lymph 165 170 908 913 I-cancer
node 171 175 914 918 I-cancer
or 176 178 919 921 O
two 179 182 922 925 O
2 183 184 926 927 O
cm 185 187 928 930 O
lung 188 192 931 935 B-cancer
lesions 193 200 936 943 I-cancer
) 200 201 943 944 O

For 0 3 945 948 O
patients 4 12 949 957 O
whose 13 18 958 963 O
CURRENT 19 26 964 971 O
disease 27 34 972 979 O
is 35 37 980 982 O
vascular 38 46 983 991 O
only 47 51 992 996 O
: 51 52 996 997 O
enhancing 53 62 998 1007 O
vascular 63 71 1008 1016 B-chronic_disease
thrombosis 72 82 1017 1027 I-chronic_disease
( 83 84 1028 1029 O
involving 84 93 1029 1038 O
portal 94 100 1039 1045 O
vein 101 105 1046 1050 O
, 105 106 1050 1051 O
IVC 107 110 1052 1055 O
and/or 111 117 1056 1062 O
hepatic 118 125 1063 1070 O
vein 126 130 1071 1075 O
) 130 131 1075 1076 O
demonstrating 132 145 1077 1090 O
early 146 151 1091 1096 O
arterial 152 160 1097 1105 O
enhancement 161 172 1106 1117 O
and 173 176 1118 1121 O
delayed 177 184 1122 1129 O
washout 185 192 1130 1137 O
on 193 195 1138 1140 O
multi 196 201 1141 1146 O
- 201 202 1146 1147 O
phasic 202 208 1147 1153 O
CT 209 211 1154 1156 B-treatment
or 212 214 1157 1159 O
MRI 215 218 1160 1163 B-treatment
in 219 221 1164 1166 O
a 222 223 1167 1168 O
patient 224 231 1169 1176 O
with 232 236 1177 1181 O
known 237 242 1182 1187 O
HCC 243 246 1188 1191 B-cancer
( 247 248 1192 1193 O
diagnosed 248 257 1193 1202 O
previously 258 268 1203 1213 O
< 269 270 1214 1215 O
720 270 273 1215 1218 B-upper_bound
days 274 278 1219 1223 I-upper_bound
) 278 279 1223 1224 O
using 280 285 1225 1230 O
the 286 289 1231 1234 O
above 290 295 1235 1240 O
criteria 296 304 1241 1249 O

HIV 0 3 1250 1253 B-chronic_disease
positive 4 12 1254 1262 O
with 13 17 1263 1267 O
CD4 18 21 1268 1271 B-clinical_variable
count 22 27 1272 1277 I-clinical_variable
< 28 29 1278 1279 O
( 30 31 1280 1281 B-upper_bound
350 31 34 1281 1284 I-upper_bound
) 34 35 1284 1285 I-upper_bound
cells 36 41 1286 1291 I-upper_bound
/ 41 42 1291 1292 I-upper_bound
microliter 42 52 1292 1302 I-upper_bound

Hemoglobin 0 10 1303 1313 B-clinical_variable
> 11 12 1314 1315 O
= 12 13 1315 1316 O
8.0 14 17 1317 1320 B-lower_bound
g 18 19 1321 1322 I-lower_bound
/ 19 20 1322 1323 I-lower_bound
dl 20 22 1323 1325 I-lower_bound

Maximal 0 7 1326 1333 O
diameter 8 16 1334 1342 O
of 17 19 1343 1345 O
any 20 23 1346 1349 O
one 24 27 1350 1353 O
hepatocellular 28 42 1354 1368 B-clinical_variable
carcinoma 43 52 1369 1378 I-clinical_variable
> 53 54 1379 1380 O
15 55 57 1381 1383 B-lower_bound
cm 58 60 1384 1386 I-lower_bound

Measureable 0 11 1387 1398 O
common 12 18 1399 1405 O
or 19 21 1406 1408 O
main 22 26 1409 1413 O
branch 27 33 1414 1420 O
biliary 34 41 1421 1428 O
duct 42 46 1429 1433 O
involvement 47 58 1434 1445 O
with 59 63 1446 1450 O
HCC 64 67 1451 1454 B-cancer

Measureable 0 11 1455 1466 O
hepatic 12 19 1467 1474 B-treatment
disease 20 27 1475 1482 I-treatment
and/or 28 34 1483 1489 O
presence 35 43 1490 1498 O
of 44 46 1499 1501 O
vascular 47 55 1502 1510 O
tumor 56 61 1511 1516 B-cancer
thrombosis 62 72 1517 1527 O
( 73 74 1528 1529 O
involving 74 83 1529 1538 O
portal 84 90 1539 1545 O
vein 91 95 1546 1550 O
, 95 96 1550 1551 O
IVC 97 100 1552 1555 O
and/or 101 107 1556 1562 O
hepatic 108 115 1563 1570 O
vein 116 120 1571 1575 O
) 120 121 1575 1576 O
which 122 127 1577 1582 O
may 128 131 1583 1586 O
not 132 135 1587 1590 O
be 136 138 1591 1593 O
measureable 139 150 1594 1605 O
as 151 153 1606 1608 O
per 154 157 1609 1612 O
Response 158 166 1613 1621 O
Evaluation 167 177 1622 1632 O
Criteria 178 186 1633 1641 O
in 187 189 1642 1644 O
Solid 190 195 1645 1650 O
Tumors 196 202 1651 1657 O
( 203 204 1658 1659 O
RECIST 204 210 1659 1665 O
) 210 211 1665 1666 O
on 212 214 1667 1669 O
liver 215 220 1670 1675 O
CT 221 223 1676 1678 B-treatment
or 224 226 1679 1681 O
MRI 227 230 1682 1685 B-treatment
, 230 231 1685 1686 O
within 232 238 1687 1693 O
28 239 241 1694 1696 B-upper_bound
days 242 246 1697 1701 I-upper_bound
of 247 249 1702 1704 O
registration 250 262 1705 1717 O

More 0 4 1718 1722 O
than 5 9 1723 1727 O
5 10 11 1728 1729 B-lower_bound
discrete 12 20 1730 1738 O
intrahepatic 21 33 1739 1751 O
parenchymal 34 45 1752 1763 O
foci 46 50 1764 1768 O
of 51 53 1769 1771 O
HCC 54 57 1772 1775 O

Pathologically 0 14 1776 1790 O
( 15 16 1791 1792 O
histologically 16 30 1792 1806 O
or 31 33 1807 1809 O
cytologically 34 47 1810 1823 O
) 47 48 1823 1824 O
proven 49 55 1825 1831 O
diagnosis 56 65 1832 1841 O
of 66 68 1842 1844 O
HCC,(biopsies 69 82 1845 1858 B-cancer
are 83 86 1859 1862 O
recommended 87 98 1863 1874 O
, 98 99 1874 1875 O
and 100 103 1876 1879 O
are 104 107 1880 1883 O
to 108 110 1884 1886 O
be 111 113 1887 1889 O
submitted 114 123 1890 1899 O
for 124 127 1900 1903 O
research 128 136 1904 1912 O
evaluation 137 147 1913 1923 O
if 148 150 1924 1926 O
patients 151 159 1927 1935 O
consent 160 167 1936 1943 O
) 167 168 1943 1944 O

Patients 0 8 1945 1953 O
must 9 13 1954 1958 O
have 14 18 1959 1963 O
a 19 20 1964 1965 O
diagnosis 21 30 1966 1975 O
of 31 33 1976 1978 O
HCC 34 37 1979 1982 B-cancer
by 38 40 1983 1985 O
at 41 43 1986 1988 O
least 44 49 1989 1994 O
one 50 53 1995 1998 B-lower_bound
criterion 54 63 1999 2008 O
listed 64 70 2009 2015 O
below 71 76 2016 2021 O
within 77 83 2022 2028 O
360 84 87 2029 2032 B-upper_bound
days 88 92 2033 2037 I-upper_bound
prior 93 98 2038 2043 I-upper_bound
to 99 101 2044 2046 O
study 102 107 2047 2052 O
entry 108 113 2053 2058 O

Platelets 0 9 2059 2068 B-clinical_variable
> 10 11 2069 2070 O
= 11 12 2070 2071 O
60,000 13 19 2072 2078 B-lower_bound
cells 20 25 2079 2084 I-lower_bound
/ 25 26 2084 2085 I-lower_bound
mm^3 26 30 2085 2089 I-lower_bound

Pregnancy 0 9 2090 2099 B-pregnancy
or 10 12 2100 2102 O
women 13 18 2103 2108 B-gender
of 19 21 2109 2111 O
childbearing 22 34 2112 2124 O
potential 35 44 2125 2134 O
and 45 48 2135 2138 O
men 49 52 2139 2142 O
who 53 56 2143 2146 O
are 57 60 2147 2150 O
sexually 61 69 2151 2159 O
active 70 76 2160 2166 O
and 77 80 2167 2170 O
not 81 84 2171 2174 B-contraception_consent
willing 85 92 2175 2182 I-contraception_consent
/ 92 93 2182 2183 I-contraception_consent
able 93 97 2183 2187 I-contraception_consent
to 98 100 2188 2190 I-contraception_consent
use 101 104 2191 2194 I-contraception_consent
medically 105 114 2195 2204 I-contraception_consent
acceptable 115 125 2205 2215 I-contraception_consent
forms 126 131 2216 2221 I-contraception_consent
of 132 134 2222 2224 I-contraception_consent
contraception 135 148 2225 2238 I-contraception_consent

Prior 0 5 2239 2244 O
invasive 6 14 2245 2253 O
malignancy 15 25 2254 2264 B-cancer
( 26 27 2265 2266 O
except 27 33 2266 2272 O
non 34 37 2273 2276 B-cancer
- 37 38 2276 2277 I-cancer
melanomatous 38 50 2277 2289 I-cancer
skin 51 55 2290 2294 I-cancer
cancer 56 62 2295 2301 I-cancer
and 63 66 2302 2305 O
T1 67 69 2306 2308 B-cancer
renal 70 75 2309 2314 I-cancer
cell 76 80 2315 2319 I-cancer
carcinoma 81 90 2320 2329 I-cancer
) 90 91 2329 2330 O
unless 92 98 2331 2337 O
disease 99 106 2338 2345 O
free 107 111 2346 2350 O
for 112 115 2351 2354 O
a 116 117 2355 2356 O
minimum 118 125 2357 2364 O
of 126 128 2365 2367 O
2 129 130 2368 2369 B-lower_bound
years 131 136 2370 2375 I-lower_bound

Prior 0 5 2376 2381 B-treatment
liver 6 11 2382 2387 I-treatment
transplant 12 22 2388 2398 I-treatment

Prior 0 5 2399 2404 B-treatment
radiotherapy 6 18 2405 2417 I-treatment
to 19 21 2418 2420 O
the 22 25 2421 2424 O
region 26 32 2425 2431 O
of 33 35 2432 2434 O
the 36 39 2435 2438 O
liver 40 45 2439 2444 O
that 46 50 2445 2449 O
would 51 56 2450 2455 O
result 57 63 2456 2462 O
in 64 66 2463 2465 O
overlap 67 74 2466 2473 O
of 75 77 2474 2476 O
radiation 78 87 2477 2486 B-treatment
therapy 88 95 2487 2494 I-treatment
fields 96 102 2495 2501 O

Prior 0 5 2502 2507 O
selective 6 15 2508 2517 O
internal 16 24 2518 2526 B-treatment
radiotherapy 25 37 2527 2539 I-treatment
/ 37 38 2539 2540 O
hepatic 38 45 2540 2547 B-treatment
arterial 46 54 2548 2556 I-treatment
yttrium 55 62 2557 2564 I-treatment
therapy 63 70 2565 2572 I-treatment
, 70 71 2572 2573 O
at 72 74 2574 2576 O
any 75 78 2577 2580 O
time 79 83 2581 2585 O

Prior 0 5 2586 2591 B-treatment
sorafenib 6 15 2592 2601 I-treatment
use 16 19 2602 2605 O
> 20 21 2606 2607 O
60 22 24 2608 2610 B-lower_bound
days 25 29 2611 2615 I-lower_bound
and/or 30 36 2616 2622 O
grade 37 42 2623 2628 O
3 43 44 2629 2630 O
or 45 47 2631 2633 O
4 48 49 2634 2635 O
sorafenib 50 59 2636 2645 O
related 60 67 2646 2653 O
toxicity 68 76 2654 2662 O

Serum 0 5 2663 2668 B-clinical_variable
creatinine 6 16 2669 2679 I-clinical_variable
= 17 18 2680 2681 O
< 18 19 2681 2682 O
2 20 21 2683 2684 B-upper_bound
x 22 23 2685 2686 I-upper_bound
ULN 24 27 2687 2690 I-upper_bound
or 28 30 2691 2693 O
creatinine 31 41 2694 2704 B-clinical_variable
clearance 42 51 2705 2714 I-clinical_variable
> 52 53 2715 2716 O
= 53 54 2716 2717 O
60 55 57 2718 2720 B-lower_bound
mL 58 60 2721 2723 I-lower_bound
/ 60 61 2723 2724 I-lower_bound
min 61 64 2724 2727 I-lower_bound

Total 0 5 2728 2733 O
sum 6 9 2734 2737 O
of 10 12 2738 2740 O
maximum 13 20 2741 2748 O
diameters 21 30 2749 2758 O
of 31 33 2759 2761 O
each 34 38 2762 2766 O
definite 39 47 2767 2775 O
parenchymal 48 59 2776 2787 O
hepatocellular 60 74 2788 2802 B-cancer
carcinoma 75 84 2803 2812 I-cancer
within 85 91 2813 2819 O
the 92 95 2820 2823 O
liver 96 101 2824 2829 O
or 102 104 2830 2832 O
maximum 105 112 2833 2840 O
diameter 113 121 2841 2849 O
of 122 124 2850 2852 O
a 125 126 2853 2854 O
single 127 133 2855 2861 O
conglomerate 134 146 2862 2874 O
HCC 147 150 2875 2878 B-clinical_variable
> 151 152 2879 2880 O
20 153 155 2881 2883 B-lower_bound
cm 156 158 2884 2886 I-lower_bound

Unsuitable 0 10 2887 2897 O
for 11 14 2898 2901 O
resection 15 24 2902 2911 B-treatment
or 25 27 2912 2914 O
transplant 28 38 2915 2925 B-treatment
or 39 41 2926 2928 O
radiofrequency 42 56 2929 2943 B-treatment
ablation 57 65 2944 2952 I-treatment
( 66 67 2953 2954 I-treatment
RFA 67 70 2954 2957 I-treatment
) 70 71 2957 2958 I-treatment

Women 0 5 2959 2964 B-gender
of 6 8 2965 2967 O
childbearing 9 21 2968 2980 O
potential 22 31 2981 2990 O
and 32 35 2991 2994 O
male 36 40 2995 2999 B-gender
participants 41 53 3000 3012 I-gender
must 54 58 3013 3017 O
agree 59 64 3018 3023 B-contraception_consent
to 65 67 3024 3026 I-contraception_consent
practice 68 76 3027 3035 I-contraception_consent
adequate 77 85 3036 3044 I-contraception_consent
contraception 86 99 3045 3058 I-contraception_consent
while 100 105 3059 3064 O
on 106 108 3065 3067 O
study 109 114 3068 3073 O
and 115 118 3074 3077 O
for 119 122 3078 3081 O
at 123 125 3082 3084 O
least 126 131 3085 3090 O
6 132 133 3091 3092 B-lower_bound
months 134 140 3093 3099 I-lower_bound
following 141 150 3100 3109 O
the 151 154 3110 3113 O
last 155 159 3114 3118 O
dose 160 164 3119 3123 O
of 165 167 3124 3126 O
radiation 168 177 3127 3136 B-treatment
therapy 178 185 3137 3144 I-treatment
( 186 187 3145 3146 I-treatment
RT 187 189 3146 3148 I-treatment
) 189 190 3148 3149 I-treatment
and 191 194 3150 3153 O
for 195 198 3154 3157 O
at 199 201 3158 3160 O
least 202 207 3161 3166 O
28 208 210 3167 3169 B-lower_bound
days 211 215 3170 3174 I-lower_bound
following 216 225 3175 3184 O
the 226 229 3185 3188 O
last 230 234 3189 3193 O
dose 235 239 3194 3198 O
of 240 242 3199 3201 O
sorafenib 243 252 3202 3211 B-treatment
( 253 254 3212 3213 O
whichever 254 263 3213 3222 O
is 264 266 3223 3225 O
later 267 272 3226 3231 O
) 272 273 3231 3232 O

Zubrod 0 6 3233 3239 B-clinical_variable
performance 7 18 3240 3251 I-clinical_variable
status 19 25 3252 3258 I-clinical_variable
0 26 27 3259 3260 B-lower_bound
- 27 28 3260 3261 O
2 28 29 3261 3262 B-upper_bound
within 30 36 3263 3269 O
28 37 39 3270 3272 B-upper_bound
days 40 44 3273 3277 I-upper_bound
prior 45 50 3278 3283 I-upper_bound
to 51 53 3284 3286 O
study 54 59 3287 3292 O
entry 60 65 3293 3298 O

benign 0 6 3299 3305 O
non 7 10 3306 3309 O
- 10 11 3309 3310 O
enhancing 11 20 3310 3319 O
periportal 21 31 3320 3330 O
lymphadenopathy 32 47 3331 3346 B-cancer
is 48 50 3347 3349 O
not 51 54 3350 3353 O
unusual 55 62 3354 3361 O
in 63 65 3362 3364 O
the 66 69 3365 3368 O
presence 70 78 3369 3377 O
of 79 81 3378 3380 O
hepatitis 82 91 3381 3390 B-chronic_disease
and 92 95 3391 3394 O
is 96 98 3395 3397 O
permitted 99 108 3398 3407 O
, 108 109 3407 3408 O
even 110 114 3409 3413 O
if 115 117 3414 3416 O
the 118 121 3417 3420 O
sum 122 125 3421 3424 B-clinical_variable
of 126 128 3425 3427 I-clinical_variable
enlarged 129 137 3428 3436 I-clinical_variable
nodes 138 143 3437 3442 I-clinical_variable
is 144 146 3443 3445 O
> 147 148 3446 3447 O
2.0 149 152 3448 3451 B-lower_bound
cm 153 155 3452 3454 I-lower_bound

carcinoma 0 9 3455 3464 B-cancer
in 10 12 3465 3467 I-cancer
situ 13 17 3468 3472 I-cancer
of 18 20 3473 3475 I-cancer
the 21 24 3476 3479 I-cancer
breast 25 31 3480 3486 I-cancer
, 31 32 3486 3487 O
oral 33 37 3488 3492 B-cancer
cavity 38 44 3493 3499 I-cancer
, 44 45 3499 3500 O
or 46 48 3501 3503 O
cervix 49 55 3504 3510 B-cancer

patients 0 8 3511 3519 O
who 9 12 3520 3523 O
are 13 16 3524 3527 O
HIV 17 20 3528 3531 B-chronic_disease
positive 21 29 3532 3540 O
are 30 33 3541 3544 O
eligible 34 42 3545 3553 O
, 42 43 3553 3554 O
provided 44 52 3555 3563 O
they 53 57 3564 3568 O
are 58 61 3569 3572 O
under 62 67 3573 3578 O
treatment 68 77 3579 3588 B-treatment
with 78 82 3589 3593 O
highly 83 89 3594 3600 B-treatment
active 90 96 3601 3607 I-treatment
antiretroviral 97 111 3608 3622 I-treatment
therapy 112 119 3623 3630 I-treatment
( 120 121 3631 3632 I-treatment
HAART 121 126 3632 3637 I-treatment
) 126 127 3637 3638 I-treatment
and 128 131 3639 3642 O
have 132 136 3643 3647 O
a 137 138 3648 3649 O
CD4 139 142 3650 3653 B-clinical_variable
count 143 148 3654 3659 I-clinical_variable
≥ 149 150 3660 3661 O
( 151 152 3662 3663 O
350 152 155 3663 3666 B-lower_bound
) 155 156 3666 3667 O
cells 157 162 3668 3673 O
/ 162 163 3673 3674 O
microliter 163 173 3674 3684 O
, 173 174 3684 3685 O
and 175 178 3686 3689 O
no 179 181 3690 3692 O
known 182 187 3693 3698 O
detectable 188 198 3699 3709 O
viral 199 204 3710 3715 O
load 205 209 3716 3720 O
, 209 210 3720 3721 O
at 211 213 3722 3724 O
the 214 217 3725 3728 O
time 218 222 3729 3733 O
of 223 225 3734 3736 O
study 226 231 3737 3742 O
entry 232 237 3743 3748 O

prior 0 5 3749 3754 B-treatment
chemotherapy 6 18 3755 3767 I-treatment
for 19 22 3768 3771 O
HCC 23 26 3772 3775 B-cancer
or 27 29 3776 3778 O
a 30 31 3779 3780 O
different 32 41 3781 3790 O
cancer 42 48 3791 3797 B-cancer

